Press 
Releases 

ARTICLES

12 November 2024
Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science

Mursla Bio was selected to support scaling and commercialization strategy for extracellular vesicle-based disease surveillance and diagnostics …

13 June 2024
Mursla Bio enters the US market with strategic expansion
Mursla Bio launches US strategy to bring its novel liquid biopsy tests – based on extracellular vesicle technology – to patients
NEXOS
3 June 2024
Mursla Bio presents breakthrough liquid biopsy technology for extracellular vesicles in Cell Press
Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press’ iScience
4 October 2023
Mursla Bio helps shape the standardisation of EV-based liquid biopsy for clinical use
Mursla Bio participates in a unique global initiative to standardise the clinical use of novel EV-based biomarkers for liquid biopsy
1 June 2023
Mursla Bio to present at Bio-International 2023
Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event